Fetal Pulse Oximetry Trial (FOX)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00098709 |
Recruitment Status :
Terminated
First Posted : December 8, 2004
Last Update Posted : March 18, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Pregnancy | Device: Fetal pulse oximeter | Phase 3 |
Information on fetal well-being during labor is of great importance to the managing physician. The current use of the fetal heart rate monitor provides some information on fetal condition, and is the primary tool used to determine if immediate operative delivery is required. The fetal pulse oximeter can provide additional information regarding fetal oxygen saturation.
Intervention: A fetal oxygen saturation sensor is placed in the uterus, between the fetal cheek or forehead and the uterine wall. In half of the patients, the managing physician will have access to fetal oxygen saturation and fetal heart rate monitoring. In the other half of the patients, labor will be monitored by fetal heart rate alone.
Study hypothesis: The additional information provided by the use of the fetal pulse oximeter will reduce the chances of a cesarean delivery. The primary outcome is cesarean section for any indication and secondary outcomes are cesarean delivery for non-reassuring fetal heart rate or dystocia, and neonatal morbidity.
Study Type : | Interventional (Clinical Trial) |
Enrollment : | 10000 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Prevention |
Official Title: | A Randomized Clinical Trial of Fetal Pulse Oximetry |
Study Start Date : | May 2002 |
Study Completion Date : | February 2005 |
- cesarean delivery (any indication)
- cesarean delivery for non-reassuring fetal heart rate
- cesarean delivery for dystocia
- neonatal morbidity

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Older Adult |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | Yes |
Inclusion criteria:
- Nulliparous
- Singleton, cephalic pregnancy
- Gestational age at least 36 weeks, 0 days
- Cervical dilatation >= 2 cm
- Station -2 or below (5ths scale)
- Ruptured membranes
- Internal monitoring devices placed
Exclusion criteria:
- Need for immediate delivery
- Planned cesarean delivery
- Cervical dilatation > 6 cm
- Known fetal anomaly or demise
- Multifetal gestation
- Maternal fever
- Placenta previa
- Previous uterine surgery
- Active HSV infection
- Known HIV or hepatitis infection
- Diabetes requiring insulin
- Heart disease requiring medication
- Known chronic renal disease
- Enrollment in another labor study

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00098709
United States, Alabama | |
University of Alabama - Birmingham | |
Birmingham, Alabama, United States, 35233 | |
United States, Illinois | |
Northwestern University | |
Chicago, Illinois, United States, 60611 | |
United States, Michigan | |
Wayne State University | |
Detroit, Michigan, United States, 48201 | |
United States, New York | |
Columbia University | |
New York, New York, United States, 10032 | |
United States, North Carolina | |
University of North Carolina - Chapel Hill | |
Chapel Hill, North Carolina, United States, 27599 | |
Wake Forest University School of Medicine | |
Winston-Salem, North Carolina, United States, 27157 | |
United States, Ohio | |
Case Western University | |
Cleveland, Ohio, United States, 44109 | |
United States, Pennsylvania | |
Dexel University | |
Philadelphia, Pennsylvania, United States, 19107 | |
University of Pittsburgh Magee Womens Hospital | |
Pittsburgh, Pennsylvania, United States, 15213 | |
United States, Rhode Island | |
Brown University | |
Providence, Rhode Island, United States, 02905 | |
United States, Texas | |
University of Texas - Southwest | |
Dallas, Texas, United States, 75235 | |
University of Texas - Houston | |
Houston, Texas, United States, 77030 | |
United States, Utah | |
University of Utah Medical Center | |
Salt Lake City, Utah, United States, 84132 |
Study Director: | Cathy Spong, MD | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | |
Principal Investigator: | Elizabeth A Thom, Ph.D. | George Washington University Biostatistics Center | |
Study Chair: | Steven L Bloom, M.D. | University of Texas |
Publications:
Responsible Party: | The George Washington University Biostatistics Center |
ClinicalTrials.gov Identifier: | NCT00098709 |
Other Study ID Numbers: |
HD36801-FOX U10HD021410 ( U.S. NIH Grant/Contract ) U10HD027869 ( U.S. NIH Grant/Contract ) U10HD027917 ( U.S. NIH Grant/Contract ) U10HD027860 ( U.S. NIH Grant/Contract ) U10HD034116 ( U.S. NIH Grant/Contract ) U10HD034208 ( U.S. NIH Grant/Contract ) U10HD034136 ( U.S. NIH Grant/Contract ) U10HD040500 ( U.S. NIH Grant/Contract ) U10HD040485 ( U.S. NIH Grant/Contract ) U10HD040544 ( U.S. NIH Grant/Contract ) U10HD040545 ( U.S. NIH Grant/Contract ) U10HD040560 ( U.S. NIH Grant/Contract ) U10HD040512 ( U.S. NIH Grant/Contract ) U10HD036801 ( U.S. NIH Grant/Contract ) |
First Posted: | December 8, 2004 Key Record Dates |
Last Update Posted: | March 18, 2022 |
Last Verified: | March 2022 |
pregnancy labor, obstetric fetal monitoring |
oximetry fetal heart rate cardiotocography |